Congratulations to Raquel Arroyo, PhD, PharmD on winning the 2024 Neonatal & Developing Lung Abstract Achievement Award.
Raquel Arroyo, PhD, PharmD is the Director of Clinical Sciences at Airway Therapeutics. She has been working with SP-D for 10+ years in academia and industry. Raquel has published several papers and presented in international scientific meetings. Her work with Surfactant Protein D (SP-D) started during her PhD in the laboratory of Dr. Perez-Gil (Spain), continued during her postdoc in the laboratory of Dr. Kingma (Cincinnati Children’s Hospital, US) and continues within Airway Therapeutics. Airway Therapeutics’ objective is to bring SP-D (zelpultide alfa) to commercialization and change the outcome of very early premature babies by preventing bronchopulmonary dysplasia.
https://www.thoracic.org/members/assemblies/interest-groups/neonatal-and-developing-lung.php
Neonatal and Developing Lung 20MAY2024
